SMTL ID : 7tz7.1

PI3K alpha in complex with an inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.41 Å

Oligo State

hetero-1-1-mer

Ligands

1 x KVJ: (4S,5R)-3-[2'-amino-2-(morpholin-4-yl)-4'-(trifluoromethyl)[4,5'-bipyrimidin]-6-yl]-4-(hydroxymethyl)-5-methyl-1,3-oxazolidin-2-one(Non-covalent)

KVJ.1: 16 residues within 4Å: Chain A: M.772, P.778, I.800, K.802, L.807, D.810, I.848, E.849, V.850, V.851, S.854, T.856, Q.859, M.922, I.932, D.933 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:I.932 Hydrogen bonds: A:K.802, A:K.802, A:V.851, A:S.854, A:D.933 Salt bridges: A:D.810, A:D.933

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Fairhurst, R.A. et al., Identification of NVP-CLR457 as an Orally Bioavailable Non-CNS-Penetrant pan-Class IA Phosphoinositol-3-Kinase Inhibitor. J.Med.Chem. (2022)

Release Date

2022-05-18

Peptides

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform: A
Isoform 3 of Phosphatidylinositol 3-kinase regulatory subunit alpha: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

Isoform 3 of Phosphatidylinositol 3-kinase regulatory subunit alpha

Related Entries With Identical Sequence